Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronaviruses.

MLA

Jeong, Ju Hwan, et al. “Evaluating Z-FA-FMK, a Host Cathepsin L Protease Inhibitor, as a Potent and Broad-Spectrum Antiviral Therapy against SARS-CoV-2 and Related Coronaviruses.” Antiviral Research, vol. 216, Aug. 2023, p. 105669. EBSCOhost, https://doi.org/10.1016/j.antiviral.2023.105669.

APA

Jeong, J. H., Choi, J.-H., Kim, B. K., Min, S. C., Chokkakula, S., Oh, S., Park, J.-H., Shim, S.-M., Kim, E.-G., Choi, Y. K., Lee, J.-Y., Baek, Y. H., & Song, M.-S. (2023). Evaluating Z-FA-FMK, a host cathepsin L protease inhibitor, as a potent and broad-spectrum antiviral therapy against SARS-CoV-2 and related coronaviruses. Antiviral Research, 216, 105669. https://doi.org/10.1016/j.antiviral.2023.105669

Chicago

Jeong, Ju Hwan, Jang-Hoon Choi, Beom Kyu Kim, Seong Cheol Min, Santosh Chokkakula, Sol Oh, Ji-Hyun Park, et al. 2023. “Evaluating Z-FA-FMK, a Host Cathepsin L Protease Inhibitor, as a Potent and Broad-Spectrum Antiviral Therapy against SARS-CoV-2 and Related Coronaviruses.” Antiviral Research 216 (August): 105669. doi:10.1016/j.antiviral.2023.105669.